Книга Пятый элемент здоровья. Как использовать менструальный цикл для поддержания жизненно важных функций организма - Лиза Хендриксон-Джек

of Implanon use on selected parameters of thyroid and adrenal function.” Contraception 62, no. 5 (2000): 247–251; Segall-Gutierrez, Penina, Joanna Du, Chunying Niu, Marshall Ge, Ian Tilley, Kelly Mizraji, and Frank Z. Stanczyk. “Effect of subcutaneous depo– medroxyprogesterone acetate (DMPA-SC) on serum androgen markers in normal-weight, obese, and extremely obese women.” Contraception 86, no. 6 (2012): 739–745.

30. Zimmerman, Y., M.J.C. Eijkemans, H.J.T. Coelingh Bennink, M.A. Blankenstein, and B.C.J.M. Fauser. “The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis.” Human Reproduction Update 20, no. 1 (2014): 76–105.

31. Anderson, David C. “Sex-hormone-binding globulin.” Clinical Endocrinology 3, no. 1 (1974): 72.

32. Panzer, Claudia, Sarah Wise, Gemma Fantini, Dongwoo Kang, Ricardo Munarriz, Andre Guay, and Irwin Goldstein. “Impact of oral contraceptives on sex hormone-binding globulin and androgen levels: a retrospective study in women with sexual dysfunction.” The Journal of Sexual Medicine 3, no. 1 (2006): 104–113; Zimmerman, Y., M.J.C. Eijkemans, H.J.T. Coelingh Bennink, M.A. Blankenstein, and B.C.J.M. Fauser. “The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis.” Human Reproduction Update 20, no. 1 (2014): 76–105; Hugon-Rodin, Justine, Martine Alhenc-Gelas, H. Coenraad Hemker, Sylvie Brailly-Tabard, Anne Guiochon-Mantel, Geneviève Plu-Bureau, and Pierre-Yves Scarabin. “Sex hormone-binding globulin and thrombin generation in women using hormonal contraception.” Biomarkers (2016): 1–5; Van Vliet, Huib A.A.M., Marijke Frolich, M. Christella, L.G.D. Thomassen, Carine J.M. Doggen, Frits R. Rosendaal, Jan Rosing, and Frans M. Helmerhorst. “Association between sex hormone-binding globulin levels and activated protein C resistance in explaining the risk of thrombosis in users of oral contraceptives containing different progestogens.” Human Reproduction 20, no. 2 (2005): 563–568.

33. Panzer, Claudia, Sarah Wise, Gemma Fantini, Dongwoo Kang, Ricardo Munarriz, Andre Guay, and Irwin Goldstein. “Impact of oral contraceptives on sex hormone-binding globulin and androgen levels: a retrospective study in women with sexual dysfunction.” The Journal of Sexual Medicine 3, no. 1 (2006): 108.

34. Там же, 110.

35. Там же, 110.

36. Mes-Krowinkel, Miranda G., Yvonne V. Louwers, Annemarie G.M.G.J. Mulders, Frank H. de Jong, Bart C.J.M. Fauser, and Joop S.E. Laven. “Influence of oral contraceptives on anthropomorphometric, endocrine, and metabolic profiles of anovulatory polycystic ovary syndrome patients.” Fertility and Sterility 101, no. 6 (2014): 1757–1765.

37. Bouchard, Céline, Jacques Brisson, Michel Fortier, Carol Morin, and Caty Blanchette. “Use of oral contraceptive pills and vulvar vestibulitis: a case-control study.” American Journal of Epidemiology 156, no. 3 (2002): 254–261; Bohm-Starke, Nina, Ulrika Johannesson, Marita Hilliges, Eva Rylander, and Erik Torebjörk. “Decreased mechanical pain threshold in the vestibular mucosa of women using oral contraceptives: A contributing factor in vulvar vestibulitis?” The Journal of Reproductive Medicine 49, no. 11 (2004): 888–892; Battaglia, Cesare, Elena Morotti, Nicola Persico, Bruno Battaglia, Paolo Busacchi, Paolo Casadio, Roberto Paradisi, and Stefano Venturoli. “Clitoral vascularization and sexual behavior in young patients treated with drospirenone – ethinyl estradiol or contraceptive vaginal ring: a prospective, randomized, pilot study.” The Journal of Sexual Medicine 11, no. 2 (2014): 471–480.

38. Bouchard, Céline, Jacques Brisson, Michel Fortier, Carol Morin, and Caty Blanchette. “Use of oral contraceptive pills and vulvar vestibulitis: a case-control study.” American Journal of Epidemiology 156, no. 3 (2002): 254–261.

39. Battaglia, Cesare, Elena Morotti, Nicola Persico, Bruno Battaglia, Paolo Busacchi, Paolo Casadio, Roberto Paradisi, and Stefano Venturoli. “Clitoral vascularization and sexual behavior in young patients treated with drospirenone – ethinyl estradiol or contraceptive vaginal ring: a prospective, randomized, pilot study.” The Journal of Sexual Medicine 11, no. 2 (2014): 471–480.

40. Battaglia, Cesare, Bruno Battaglia, Fulvia Mancini, Paolo Busacchi, Maria Chiara Paganotto, Elena Morotti, and Stefano Venturoli. “Sexual behavior and oral contraception: A pilot study.” The Journal of Sexual Medicine 9, no. 2 (2012): 550–557.

41. Battaglia, Cesare, Elena Morotti, Nicola Persico, Bruno Battaglia, Paolo Busacchi, Paolo Casadio, Roberto Paradisi, and Stefano Venturoli. “Clitoral vascularization and sexual behavior in young patients treated with drospirenone – ethinyl estradiol or contraceptive vaginal ring: a prospective, randomized, pilot study.” The Journal of Sexual Medicine 11, no. 2 (2014): 471–480.

42. Hendrickson-Jack, Lisa. “FFP 007 | What the Pill Really Does to Your Hormones | PCOS & Menstrual Irregularities | Dr. Lara Briden.” Fertility Friday Podcast. Podcast Audio, January 30, 2015. fertilityfriday.com/lara.

43. Lee, Joo Yong, and Kang Su Cho. “Chemical castration for sexual offenders: physicians’ views.” Journal of Korean Medical Science 28, no. 2 (2013): 171–172; Heim, Nikolaus. “Sexual behavior of castrated sex offenders.” Archives of Sexual Behavior 10, no. 1 (1981): 11–19.

44. Skovlund, Charlotte Wessel, Lina Steinrud Mørch, Lars Vedel Kessing, and Øjvind Lidegaard. “Association of hormonal contraception with depression.” JAMA Psychiatry 73, no. 11 (2016): 1154–1162; Lundin, Cecilia, Kristina Gemzell Danielsson, Marie Bixo, Lena Moby, Hanna Bengtsdotter, Izabella Jawad, Lena Marions et al. “Combined oral contraceptive use is associated with both improvement and worsening of mood in the different phases of the treatment cycle – A double-blind, placebo-controlled randomized trial.” Psychoneuroendocrinology 76 (2017): 135–143; Sirakov, M., and E. Tomova. “Oral contraceptives and mood/sexual disorders in women.” Akusherstvo I Ginekologiia 54, no. 5 (2014): 34–40; Oinonen, Kirsten A., and Dwight Mazmanian. “To what extent do oral contraceptives influence mood and affect?” Journal of Affective Disorders 70, no. 3 (2002): 229–240; Herzberg, Brenda N., Anthony L. Johnson, and Susannah Brown. “Depressive symptoms and oral contraceptives.” The BMJ 4, no. 5728 (1970): 142–145.

45. Skovlund, Charlotte Wessel, Lina Steinrud Mørch, Lars Vedel Kessing, and Øjvind Lidegaard. “Association of hormonal contraception with depression.” JAMA Psychiatry 73, no. 11 (2016): 1161.

46. Cowen, Philip J., and Michael Browning. “What has serotonin to do with depression?” World Psychiatry 14, no. 2 (2015): 158–160; Adams, P.W., V. Wynn, D.P. Rose, M. Seed, J. Folkard, and R. Strong. “Effect of pyridoxine hydrochloride (vitamin B6) upon depression associated with oral contraception.” The Lancet 301, no. 7809 (1973): 897–904; Birdsall, Timothy C. “5-Hydroxytryptophan: a clinically-effective serotonin precursor.” Alternative Medicine Review: A Journal of Clinical Therapeutic 3, no. 4 (1998): 271–280.

47. Var, Chivorn, Sheryl Keller, Rathavy Tung, Dylan Freeland, and Alessandra N. Bazzano. “Supplementation with vitamin B6 reduces side effects in Cambodian women using oral contraception.” Nutrients 6, no. 9 (2014): 3353–3362; Leeton, John. “Depression induced by oral contraception and the role of vitamin B6 in its management.” Australian and New Zealand Journal of Psychiatry 8, no. 2